Skip to content

Clinical trials

Completed Phase 3 Lung Diseases, Interstitial trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lung Diseases, Interstitial Phase: Phase 3 Status: Completed Clear all

19 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20072
20081
20121
20131
20161
20174
20192
20212
20225

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed19

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Boehringer Ingelheim7
Actelion2
United Therapeutics2
Assistance Publique - Hôpitaux de Paris1
Dr. Denis O'Donnell1
Eric Matteson1
NPO Petrovax1
Post Graduate Institute of Medical Education and Research, Chandigarh1
Sanjay Gandhi Postgraduate Institute of Medical Sciences1
University Hospital, Tours1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lung Diseases, Interstitial19
Idiopathic Pulmonary Fibrosis4
Scleroderma, Diffuse3
Fibrosis2
Pulmonary Fibrosis2
Scleroderma, Systemic2
Arthritis, Rheumatoid1
COVID-191
Connective Tissue Diseases1
Disease1

Trials

Showing 1 to 19 of 19. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.